Showing results (141-150 of 193) with videos related to

Sort By:
Pageof 20
Immunotherapy|June 27, 2025
Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitorsTaha Koray Sahin, Deniz Can Guven, Yakup Ozbay, et al.
Medicina (Kaunas, Lithuania)|November 27, 2025
Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. <i>Medicina</i> 2025, <i>61</i>, 638Ziya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Expert Review of Clinical Pharmacology|November 13, 2025
Immunotherapy in biliary tract cancer: effective but not enough?Alessandro Rizzo, Enes Erul, Deniz Can Guven, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 12, 2021
Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapyDeniz Can Guven, Melek Seren Aksun, Taha Koray Sahin, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) StudyZiya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Cancers|March 13, 2024
Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving ChemotherapyGürkan Güner, Levent Özçakar, Yusuf Baytar, et al.
International Journal of Cancer|September 9, 2022
Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapyDeniz Can Guven, Fatma Gul Gulbahce Incesu, Hasan Cagri Yildirim, et al.
BMJ Supportive & Palliative Care|July 16, 2020
COVID-19 pandemic: changes in cancer admissionsDeniz Can Guven, Burak Yasin Aktas, Melek Seren Aksun, et al.
Immunotherapy|October 22, 2021
Thirty-day mortality rates after immunotherapy initiationOsman Sütcüoğlu, Ayşegül İlhan, Seher Yıldız Tacar, et al.
Integrative Cancer Therapies|October 5, 2024
The Use of Herbal Medicine and Dietary Supplements in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Cross-Sectional StudyFatih Kus, Deniz Can Guven, Hasan Cagri Yildirim, et al.
Pageof 20